Pharmacology/ Therapeutics News for April 2017

Pharmacology/ Therapeutics News Archive

Metastatic breast cancers: Characterising the profile of metastases for improved treatment Metastatic breast cancers: Characterising the profile of metastases for improved treatment

Researchers at the Jules Bordet Institute - Université libre de Bruxelles, VIB and KU Leuven published this 21 of April an important study offering a better understanding of the progression of breast cancer. The conclusions could have an impact on care for patients suffering from a metastatic breast cancer. This is one of the first studies based on the analysis of multiple metastases obtained at the time of patient autopsies.

CRT Pioneer Fund, Cancer Research UK and NCI Collaborate to Boost Research Against the ‘Undruggable’ RAS CRT Pioneer Fund, Cancer Research UK and NCI Collaborate to Boost Research Against the ‘Undruggable’ RAS

Cancer Research UK and the Cancer Research Technology Pioneer Fund (CPF) have committed £2.5 million in collaboration with the National Cancer Institute (NCI) in the US to tackle one of the toughest challenges in cancer that has thwarted researchers for more than 30 years.

Mission Therapeutics and University of Oxford Awarded Research Grant from the Michael J. Fox Foundation Mission Therapeutics and University of Oxford Awarded Research Grant from the Michael J. Fox Foundation

Collaborative team to progress novel USP30 inhibitors to develop potential therapies for Parkinson’s disease

Drugs targeted against Fractalkine signaling poised to offer major breakthrough in the treatment of autoimmune diseases and cancer Drugs targeted against Fractalkine signaling poised to offer major breakthrough in the treatment of autoimmune diseases and cancer

Non-specific immune system becomes increasing area of focus